Bio-Medicine
Bio-Medicine
Strong ties with Chinese Bio-Medicine giant 3S Bio
Covering oncology, autoimmune diseases, nephrology, and other related areas.
Details
Details
Details
Three R&D platforms, including two protein-based biopharmaceutical platforms (a cellular platform for mammalian expression system and a platform for bacterial cell expression system) and a chemical platform.
Platform for mammalian cell expression system. Through this platform, we develop biopharmaceutical products expressed in mammalian cells. Our core products, EPIAO and TPIAO, are developed through our mammalian cell platform. In addition, we use this platform to develop monoclonal antibody drugs.
Platform for bacterial cell expression system. Through this platform, we develop biopharmaceutical products expressed in bacterial cells. Our early products, Intefen and Inleusin are developed through our platform for bacterial cell expression system.
Chemical platform. Through this platform, we mainly cooperate with third-party companies and research institutions to develop chemical drugs.
Three R&D platforms, including two protein-based biopharmaceutical platforms (a cellular platform for mammalian expression system and a platform for bacterial cell expression system) and a chemical platform.
Platform for mammalian cell expression system. Through this platform, we develop biopharmaceutical products expressed in mammalian cells. Our core products, EPIAO and TPIAO, are developed through our mammalian cell platform. In addition, we use this platform to develop monoclonal antibody drugs.
Platform for bacterial cell expression system. Through this platform, we develop biopharmaceutical products expressed in bacterial cells. Our early products, Intefen and Inleusin are developed through our platform for bacterial cell expression system.
Chemical platform. Through this platform, we mainly cooperate with third-party companies and research institutions to develop chemical drugs.
Three R&D platforms, including two protein-based biopharmaceutical platforms (a cellular platform for mammalian expression system and a platform for bacterial cell expression system) and a chemical platform.
Platform for mammalian cell expression system. Through this platform, we develop biopharmaceutical products expressed in mammalian cells. Our core products, EPIAO and TPIAO, are developed through our mammalian cell platform. In addition, we use this platform to develop monoclonal antibody drugs.
Platform for bacterial cell expression system. Through this platform, we develop biopharmaceutical products expressed in bacterial cells. Our early products, Intefen and Inleusin are developed through our platform for bacterial cell expression system.
Chemical platform. Through this platform, we mainly cooperate with third-party companies and research institutions to develop chemical drugs.
Have Additional Questions?
Have Additional Questions?
Have Additional Questions?
